Archetype : openEHR-EHR-CLUSTER.medication

Modellbiblioteket openEHR Fork

Name

Medication details

Description

Details about a medication or component of a medication, including strength, form and details of any specific constituents.

Keywords

medication order prescribe therapy substance drug therapeutic therapeutic good ad-hoc adhoc ad hoc extemporaneous formulation medicine

Purpose

To record details about a medication or component of a medication, including strength, form and details of any specific constituents.

Use

Use to record details about a medication or component of a medication, including strength, form and details of any specific constituents.

This archetype is intended to be used to record details of a medication or component of a medication where the form and detailed ingredients of the medication need to be specified in more detail, for example, infusions and ad hoc mixtures, or where there is no medication terminology available. In the context of an order for administration or dispensing of a medication, nest this archetype within the 'Medication details' SLOT within the INSTRUCTION.medication_order archetype. In the context of recording the actual administration or dispensing or a medication, nest this archetype within the 'Medication details' SLOT within the ACTION.medication archetype.

This archetype may be redundant in situations where ordering a medication via prescription uses a terminology to identify the medication item. In that case the brand or product name may identify the form and strength of the substance.

Misuse

Not to be used for pharmacy stock-control or within medication catalogues.

Not to be used to record the intended or administered dose of a medication. Use either the INSTRUCTION.medication_order or the CLUSTER.dosage archetypes for this purpose.

Not to be used by itself to populate a medication list. Use a relevant medication-related ENTRY archetype such as INSTRUCTION.medication_order or ACTION.medication for this purpose.

References

ISO 11238:2018, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated information on substances. Available from: https://www.iso.org/standard/69697.html.

ISO 11239:2012, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated information on pharmaceutical dose forms, units of presentation, routes of administration and packaging. Available from: https://www.iso.org/standard/55032.html.

ISO 11240:2012, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of units of measurement. Available from: https://www.iso.org/standard/55033.html.

ISO 11616:2017, Health informatics -- Identification of medicinal products -- Data elements and structures for unique identification and exchange of regulated pharmaceutical product information. Available from: https://www.iso.org/standard/70044.html.

ISO 11615:2017, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated medicinal product information. Available from: https://www.iso.org/standard/70150.html.

FHIR Resource Medication, HL7 [Internet]. Available at: https://www.hl7.org/fhir/medication.html (Accessed 12 April 2018)

Archetype Id

openEHR-EHR-CLUSTER.medication.v2

Licencing

This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/3.0/.

Original Author

Silje Ljosland Bakke
Nasjonal IKT HF

Date Originally Authored

To record details about a medication or component of a medication, including strength, form and details of any specific constituents.

Language	Details
German	Ramona Wellmann, Natalia Strauch Medizinische Hochschule Hannover
Swedish	Sofia Janstad SLL
Norwegian Bokmal	Silje Ljosland Bakke Nasjonal IKT HF, Helse Vest IKT AS
Portuguese	Beatriz de Faria Leao Bleao Informática em Saúde
Dutch	Joost Holslag Nedap

Name	Card	Type	Description
Name	0..1	DV_TEXT	The name of the medication or medication component. Comment For example: 'Zinacef 750 mg powder' or 'cefuroxim'. This item should be coded if possible, using for example, RxNorm, DM+D, Australian Medicines Terminology or FEST. Usage of this element will vary according to context of use. This element may be omitted where the name of the medication is recorded in the parent INSTRUCTION or ACTION archetype, and this archetype is only used to record that the form must be or was 'liquid'.
Form	0..*	DV_TEXT	The formulation or presentation of the medication or medication component. Comment For example: 'tablet', 'capsule', 'cream', 'infusion fluid' or 'inhalation powder'. Coding of the form with a terminology is preferred, where possible. Medicines catalogues may differentiate between administrable form 'solution for injection' and product form 'powder for solution for injection'. The recorded form will depend on the exact context of use but administrable form is likely to be used in most instances.
Category	0..1	CHOICE OF DV_CODED_TEXT DV_TEXT	The category of the medication or medication component, with regard to manufacturing or preparation, and the number of ingredients. Comment For example: 'Paracetamol/codeine' is a Multi-ingredient product, while 'Morphine 60 mg + Haloperidol 2 mg + Midazolam 5 mg' is an Ad-hoc mixture, whose composition is fully specified within the order. Constraint for DV_CODED_TEXT Ad-hoc mixture [The medication or medication component is composed of a mixture of ingredients specified within the order. These are typically prepared by pharmacy or ward personnel to suit individual patients.] Ingredient [The medication or medication component is an individual ingredient of the medication. This term is used when the archetype is nested within a parent instance of itself, to describe the individual ingredients of a medication.] Multi-ingredient product [The medication or medication component consists of a number of active ingredients which are pre-combined into a single form such as a tablet, cream or powder by the manufacturer, for example Paracetamol/codeine.] Single-ingredient product [The medication or medication component is a manufactured product containing a single active ingredient.] Combination product [The medication or medication component consists of a number of separate products which are pre-packaged by the manufacturer, for example Canesten Combi.]
Strength (presentation)	0..1	CLUSTER	The strength of the medication or medication component, expressed as a ratio. Comment In some cases, as for liquid or semisolid medications, the denominator of the strength ratio is a physical quantity, for example 2 mg/5 ml. In some of these cases the denominator also reflects the actual volume of the component: 5 ml in the previous example. In this case the 'Strength (concentration)' would be 0.4 mg/ml. In other cases, where the strength involves a denominator which is not a physical quantity, for example 4 mg/tablet, the denominator is expressed as a unitary value '1' with a unit of 'tablet'. This arrangement was chosen to align with the approach adopted by the ISO IDMP standard for medication catalogues. If the 'Strength (concentration)' element is used, this cluster becomes redundant. CLUSTER
Strength numerator	1..1	DV_QUANTITY	The numerator of the strength fraction. Comment For example: For a presentation strength of '300 µg/0.3 ml', the strength numerator is '300 µg'. For a presentation strength of '100 mg/tablet', the strength numerator value is '100 mg'. DV_QUANTITY
Strength denominator	1..1	DV_QUANTITY	The denominator of the strength fraction. Comment For example: For a presentation strength of '300 µg/0.3 ml', the strength denominator value is '0.3 ml'. For a presentation strength of '100 mg/tablet', the strength denominator value is '1 tablet'. DV_QUANTITY
Strength (concentration)	0..1	DV_QUANTITY	The strength of the medication or medication component, as a concentration. Comment This element is used for liquid or semisolid medications, or medications intended to be diluted in a liquid before administration. For example: '10 mg/ml', '20 mg/g', '5 %', '10,000 SQ-U/ml'. If the 'Strength (presentation)' cluster is used, this element becomes redundant. DV_QUANTITY
Manufacturer	0..1	DV_TEXT	The manufacturer of the medication or medication component. Comment For example: 'Abbott'.
Batch ID	0..*	CHOICE OF DV_TEXT DV_IDENTIFIER	The identifier assigned to the production batch by the manufacturer during production. DV_IDENTIFIER
Expiry	0..1	DV_DATE_TIME	The expiry date and/or time of the medication or medication component, as given by the manufacturer or individual preparing the mixture. Comment Any other form of expiry date, such as time from production or depending on storage environment, can be inserted using a specific CLUSTER archetype in the Substance Details slot or added as part of the Description. For example: '2017-05-23'. DV_DATE_TIME
Constituent	0..*	Slot (Cluster)	Details of an ingredient or product used to make up a mixed pack, preparation or infusion. Comment This slot is intended to be used to add details about constituents of the medication or medication component, using nested instances of this archetype. This is not normally required other than where a mixture is being described. Slot Slot
Amount	0..1	DV_QUANTITY	The amount of medication or medication component. Comment For example: '1 ml', '1.5 mg', '1000 ml'. DV_QUANTITY
Alternate amount	0..1	DV_QUANTITY	An equivalent representation of the amount of the medication or medication component. Comment For example: for a medication with a strength of '5 mg/ml' and where the Amount is '1 ml', and the value recorded in this data element would be '5 mg'. DV_QUANTITY
Role	0..1	CHOICE OF DV_CODED_TEXT DV_TEXT	The role of the medication or medication component within a mixture. Constraint for DV_CODED_TEXT Therapeutic [Constituent that alone or in combination with one or more other ingredients is considered to fulfil the intended activity of a medicinal product.] Adjuvant [Constituent whose primary function is to modify the activity of an active constituent. An adjuvant constituent itself may or may not be therapeutically active.] Excipient [Constituent that is inert in relation to the intended activity of the medicinal product.]
Description	0..1	DV_TEXT	Narrative description of the medication or medication component where it is not possible to describe this fully using structured elements.
Structured details	0..*	Slot (Cluster)	Additional details about the medication or medication component. Comment For example: detailed information about the drug class or intended routes, or additional expiry information. Slot Slot

archetype (adl_version=1.4; uid=b222a76b-6f91-4e78-b669-0d776747a789)
	openEHR-EHR-CLUSTER.medication.v2

concept
	[at0000]	-- Medication details
language
	original_language = <[ISO_639-1::en]>
	translations = <
		["de"] = <
			language = <[ISO_639-1::de]>
			author = <
				["name"] = <"Ramona Wellmann, Natalia Strauch">
				["organisation"] = <"Medizinische Hochschule Hannover">
				["email"] = <"wellmann.ramona@mh-hannover.de, Strauch.Natalia@mh-hannover.de">
			>
		>
		["sv"] = <
			language = <[ISO_639-1::sv]>
			author = <
				["name"] = <"Sofia Janstad">
				["organisation"] = <"SLL">
				["email"] = <"sofia.lang-janstad@sll.se">
			>
		>
		["nb"] = <
			language = <[ISO_639-1::nb]>
			author = <
				["name"] = <"Silje Ljosland Bakke">
				["organisation"] = <"Nasjonal IKT HF, Helse Vest IKT AS">
				["email"] = <"silje.ljosland.bakke@helse-vest-ikt.no">
			>
		>
		["pt"] = <
			language = <[ISO_639-1::pt]>
			author = <
				["name"] = <"Beatriz de Faria Leao">
				["organisation"] = <"Bleao Informática em Saúde">
				["email"] = <"bfleao@terra.com.br">
			>
			accreditation = <"MD, PhD">
		>
		["nl"] = <
			language = <[ISO_639-1::nl]>
			author = <
				["name"] = <"Joost Holslag">
				["organisation"] = <"Nedap">
				["email"] = <"joost.holslag@nedap.com">
			>
			accreditation = <"MD">
		>
	>
description
	original_author = <
		["name"] = <"Silje Ljosland Bakke">
		["organisation"] = <"Nasjonal IKT HF">
		["email"] = <"silje.ljosland.bakke@nasjonalikt.no">
		["date"] = <"2018-06-07">
	>
	details = <
		["de"] = <
			language = <[ISO_639-1::de]>
			purpose = <"Zur Darstellung von Details eines Arzneimittels oder einer Komponente eines Arzneimittels, einschließlich der Wirkstärke, der Darreichungsform und den Details über bestimmte Inhaltsstoffe.">
			use = <"Zur Darstellung von Angaben zu einem Arzneimittel oder einer Arzneimittelkomponente, einschließlich der Wirkstärke, der Darreichungsform und den Angaben über spezielle Inhaltsstoffe.

Dieser Archetyp soll für die Darstellung von Angaben zu einem Arzneimittel oder einer Arzneimittelkomponente verwendet werden. Dabei sollen vor allem die Darreichungsform und die Inhaltsstoffe detailliert beschrieben werden, z.B. zu einer Infusion oder einer Ad-hoc-Mixtur oder wenn es zu einem Arzneimittel keine Terminologie zur Verfügung steht. Im Rahmen einer Verordnung oder Abgabe eines Arzneimittels kann dieser Archetyp in den SLOT \"Arzneimitteldetails\" innerhalb des INSTRUCTION.medication_order Archetyps eingebettet werden. Für die Darstellung einer gegenwärtigen Verabreichung, Abgabe oder Anwendung eines Arzneimittels muss dieser Archetyp innerhalb des SLOTs \"Arzneimitteldetails\" in den Archetyp ACTION.medication eingefügt werden.

Dieser Archetyp kann überflüssig sein, wenn die Verordnung eines verschreibungsfähigen Arzneimittels eine Terminologie zur Identifizierung des Arzneimittelproduktes verwendet. In diesem Fall kann der Marken- oder Produktname Informationen über die Darreichungsform und die Wirkstärke der Stoffe beinhalten.
">
			keywords = <"Arzneimittel", "Medikament", "Verordnung", "Verschreibung", "Rezept", "ein Rezept ausstellen", "Therapie", "Substanz", "Stoff", "Arznei", "Therapeutikum", "Wirkstoff", "Heilmittel", "ad-hoc", "ad hoc", "Rezeptur", "Zusammensetzung", "Medizin", "Pharmakon">
			misuse = <"Nicht für die Kontrolle des Apothekenbestands oder zur Verwaltung von Arzneimittellisten verwenden.

Nicht zur Darstellung einer beabsichtigten oder verabreichten Dosis eines Arzneimittels einsetzen. Für diesen Zweck müssen die Archetypen INSTRUCTION.medication_order oder CLUSTER.dosage verwendet werden.

Darf nicht allein zum Ausfüllen einer Medikamentenliste verwendet werden. Verwenden Sie dazu einen relevanten medikamentenbezogenen ENTRY-Archetyp wie INSTRUCTION.medication_order oder ACTION.medication.">
		>
		["sv"] = <
			language = <[ISO_639-1::sv]>
			purpose = <"För att registrera information om ett läkemedel eller en läkemedelskomponent, inklusive styrka, form och detaljer om någon specifika beståndsdel.">
			use = <"*Use to record details about a medication or component of a medication, including strength, form and details of any specific constituents.

This archetype is intended to be used to record details of a medication or component of a medication where the form and detailed ingredients of the medication need to be specified in more detail, for example, infusions and ad hoc mixtures, or where there is no medication terminology available. In the context of an order for administration or dispensing of a medication, nest this archetype within the Preparation details SLOT within the INSTRUCTION.medication_order archetype. In the context of recording the actual administration or dispensing or a medication, nest this archetype within the 'Medication details' SLOT within the ACTION.medication archetype.

This archetype may be redundant in situations where ordering a medication via prescription uses a terminology to identify the medication item. In that case the brand or product name may identify the form and strength of the substance. (en)">
			keywords = <"läkemedel", "beställnförskrivning", "terapi", "substans", "drog eller läkemedel", "behandlingsavsikt", "therapeutic good", "ad-hoc", "adhoc", "ad hoc", "*extemporaneous", "läkemedelsform", "farmaceutisk produkt">
			misuse = <"*Not to be used for pharmacy stock-control or within medication catalogues.

Not to be used to record the intended or administered dose of a medication. Use either the INSTRUCTION.medication_order or the CLUSTER.dosage archetypes for this purpose.

Not to be used by itself to populate a medication list. Use a relevant medication-related ENTRY archetype such as INSTRUCTION.medication_order or ACTION.medication for this purpose. (en)">
		>
		["pt"] = <
			language = <[ISO_639-1::pt]>
			purpose = <"Para registrar detalhes de uma preparação de medicamentos, incluindo, quando necessário, detalhes de múltiplos ingredientes, no contexto de uma infusão ou preparação ad-hoc (manipulada). A maioria das prescrições baseadas em dose terá sua precisa preparação determinada pelo estoque disponível na unidade, ou pelo fornecimento de farmácia, enquanto que, com a prescrição baseada em produtos, o nome da medicação traz detalhes da forma e concentração da preparação.">
			use = <"*Use to record details about a medication or component of a medication, including strength, form and details of any specific constituents.

This archetype is intended to be used to record details of a medication or component of a medication where the form and detailed ingredients of the medication need to be specified in more detail, for example, infusions and ad hoc mixtures, or where there is no medication terminology available. In the context of an order for administration or dispensing of a medication, nest this archetype within the Preparation details SLOT within the INSTRUCTION.medication_order archetype. In the context of recording the actual administration or dispensing or a medication, nest this archetype within the 'Medication details' SLOT within the ACTION.medication archetype.

This archetype may be redundant in situations where ordering a medication via prescription uses a terminology to identify the medication item. In that case the brand or product name may identify the form and strength of the substance. (en)">
			keywords = <"medicação", "ordem", "prescrever", "terapia", "substância", "droga", "terapêutico", "venda livre", "ítem terapêutico", "Ad hoc", "manipulados">
			misuse = <"*Not to be used for pharmacy stock-control or within medication catalogues.

Not to be used to record the intended or administered dose of a medication. Use either the INSTRUCTION.medication_order or the CLUSTER.dosage archetypes for this purpose.

Not to be used by itself to populate a medication list. Use a relevant medication-related ENTRY archetype such as INSTRUCTION.medication_order or ACTION.medication for this purpose. (en)">
		>
		["nb"] = <
			language = <[ISO_639-1::nb]>
			purpose = <"For å registrere detaljer om et legemiddel eller en komponent av et legemiddel, inkludert detaljer om spesifikke bestanddeler.">
			use = <"Brukes for å registrere detaljer om et legemiddel eller en komponent av et legemiddel, inkludert detaljer om spesifikke bestanddeler.

Denne arketypen er laget for å brukes til å registrere detaljer om et legemiddel eller en komponent av et legemiddel, der formen og detaljer om bestanddelene må oppgis i mer detalj. Eksempler kan være infusjoner og magistrellforskrevne blandinger, eller der det ikke finnes en tilgjengelig legemiddelterminologi. I sammenhenger der et legemiddel skal administreres eller ekspederes skal denne arketypen nøstes i SLOTet Legemiddeldetaljer i arketypen INSTRUCTION.medication_order. I sammenhenger der det skal registreres hvilket legemiddel som faktisk ble administrert eller ekspedert skal denne arketypen nøstes i SLOTet Legemiddeldetaljer i arketypen ACTION.medication.

Denne arketypen kan være overflødig i situasjoner der en legemiddelordinering via resept bruker terminologi for å spesifisere legemiddelet. I slike tilfeller vil ofte form og styrke være angitt som en del av terminologibegrepet.">
			keywords = <"legemiddel", "tilbereding", "ordinering", "forskrive", "terapi", "substans", "medikament", "terapeutisk", "medikamenter solgt over disk", "vare", "magistrell", "ex tempore", "blanding", "virkestoff", "hjelpestoff", "utblanding", "foreskrive", "forordne">
			misuse = <"Skal ikke brukes innen varelageroversikt for apotek, eller innen legemiddelkataloger.

Skal ikke brukes for å registrere den tilsiktede eller administrerte dosen av et legemiddel. Bruk enten INSTRUCTION.medication_order eller CLUSTER.dosage til dette formålet.

Skal ikke brukes alene for å populere en legemiddelliste. Bruk en relevant legemiddel-relatert ENTRY-arketype som INSTRUCTION.medication_order eller ACTION.medication for dette formålet.">
		>
		["en"] = <
			language = <[ISO_639-1::en]>
			purpose = <"To record details about a medication or component of a medication, including strength, form and details of any specific constituents.">
			use = <"Use to record details about a medication or component of a medication, including strength, form and details of any specific constituents.

This archetype is intended to be used to record details of a medication or component of a medication where the form and detailed ingredients of the medication need to be specified in more detail, for example, infusions and ad hoc mixtures, or where there is no medication terminology available. In the context of an order for administration or dispensing of a medication, nest this archetype within the 'Medication details' SLOT within the INSTRUCTION.medication_order archetype. In the context of recording the actual administration or dispensing or a medication, nest this archetype within the 'Medication details' SLOT within the ACTION.medication archetype.

This archetype may be redundant in situations where ordering a medication via prescription uses a terminology to identify the medication item. In that case the brand or product name may identify the form and strength of the substance.">
			keywords = <"medication", "order", "prescribe", "therapy", "substance", "drug", "therapeutic", "therapeutic good", "ad-hoc", "adhoc", "ad hoc", "extemporaneous", "formulation", "medicine">
			misuse = <"Not to be used for pharmacy stock-control or within medication catalogues.

Not to be used to record the intended or administered dose of a medication. Use either the INSTRUCTION.medication_order or the CLUSTER.dosage archetypes for this purpose.

Not to be used by itself to populate a medication list. Use a relevant medication-related ENTRY archetype such as INSTRUCTION.medication_order or ACTION.medication for this purpose.">
			copyright = <"© openEHR Foundation">
		>
		["nl"] = <
			language = <[ISO_639-1::nl]>
			purpose = <"Het vastleggen van gegevens over een medicament of een onderdeel van een medicament, inclusief sterkte, vorm en details van een specifiek bestandsdeel.">
			use = <"*Use to record details about a medication or component of a medication, including strength, form and details of any specific constituents.

This archetype is intended to be used to record details of a medication or component of a medication where the form and detailed ingredients of the medication need to be specified in more detail, for example, infusions and ad hoc mixtures, or where there is no medication terminology available. In the context of an order for administration or dispensing of a medication, nest this archetype within the Preparation details SLOT within the INSTRUCTION.medication_order archetype. In the context of recording the actual administration or dispensing or a medication, nest this archetype within the 'Medication details' SLOT within the ACTION.medication archetype.

This archetype may be redundant in situations where ordering a medication via prescription uses a terminology to identify the medication item. In that case the brand or product name may identify the form and strength of the substance. (en)">
			keywords = <"medicatie", "recept", "voorschrijven", "behandeling", "substantie", "medicament", "therapeuticum", "therapeutische substantie", "ad-hoc", "adhoc", "ad hoc", "medicijn">
			misuse = <"*Not to be used for pharmacy stock-control or within medication catalogues.

Not to be used to record the intended or administered dose of a medication. Use either the INSTRUCTION.medication_order or the CLUSTER.dosage archetypes for this purpose.

Not to be used by itself to populate a medication list. Use a relevant medication-related ENTRY archetype such as INSTRUCTION.medication_order or ACTION.medication for this purpose. (en)">
		>
	>
	lifecycle_state = <"published">
	other_contributors = <"Morten Aas, Oslo Universitetssykehus, Norway", "Vebjørn Arntzen, Oslo University Hospital, Norway (openEHR Editor)", "Silje Ljosland Bakke, Helse Vest IKT AS, Norway (openEHR Editor)", "John Bennett, NEHTA, Australia", "SB Bhattacharyya, Bhattacharyyas Clinical Records Research & Informatics LLP, India", "Sharmila Biswas, Australia", "Laila Bruun, Oslo universitetssykehus HF, Norway", "Stephen Chu, NEHTA, Australia (Editor)", "Matthew Cordell, NEHTA, Australia", "Duncan Cripps, University Hospitals Plmyouth NHS Trust, United Kingdom", "Lisbeth Dahlhaug, Helse Midt - Norge IT, Norway", "Gail Easterbrook, Flinders Medical Centre, Australia", "Stig Erik Hegrestad, Helse Førde, Norway", "David Evans, Queensland Health, Australia", "Sarah Gaunt, NEHTA, Australia", "Heather Grain, Llewelyn Grain Informatics, Australia", "Trina Gregory, cpc, Australia", "Sam Heard, Ocean Health Systems, Australia", "Hilde Hollås, DIPS AS, Norway", "Roar Holm, Helse Vest IKT A/S, Norway", "Alfred Honore, Haukeland, Norway", "Evelyn Hovenga, EJSH Consulting, Australia", "Lars Ivar Mehlum, Helse Bergen HF, Norway", "Patrícia Ivo, Prefeitura Municipal de Fortaleza, Brazil", "Tom Jarl Jakobsen, Helse Bergen, Norway", "Mary Kelaher, NEHTA, Australia", "Nils Kolstrup, Skansen Legekontor og Nasjonalt Senter for samhandling og telemedisin, Norway", "Harmony Kosola, Alberta Health Services, Canada", "Robert L'egan, NEHTA, Australia", "Mitja Lapajne, Marand, Slovenia", "Anette Larsson, Tieto Sweden AB, Sweden", "Heather Leslie, Atomica Informatics, Australia (openEHR Editor)", "Mark Luciani, Bath and North East Somerset, Swindon and Wiltshire Clinical Commisioning Group, United Kingdom", "Colin Macfarlane, Elsevier, United Kingdom", "Siv Marie Lien, DIPS ASA, Norway", "James McClay, University of Nebraska Medical Center, United States", "Susan McIndoe, Royal District Nursing Service, Australia", "David McKillop, NEHTA, Australia", "Hildegard McNicoll, freshEHR Clinical Informatics Ltd., United Kingdom", "Ian McNicoll, freshEHR Clinical Informatics, United Kingdom (openEHR Editor)", "Chris Mitchell, RACGP, Australia", "Stewart Morrison, NEHTA, Australia", "Andrej Orel, Marand d.o.o., Slovenia", "doug pankoski, Alberta Health Services, Canada", "Chris Pearce, Melbourne East GP Network, Australia", "Vladimir Pizzo, Clínica Parente Pizzo, Finland", "Camilla Preeston, Royal Australian College of General Practitioners, Australia", "Margaret Prichard, NEHTA, Australia", "Cathy Richardson, NEHTA, Australia", "Robyn Richards, NEHTA - Clinical Terminology, Australia", "Jussara Rotzsch, Hospital Alemão Oswaldo Cruz, Brazil", "Martha Schei Hynne, The Norwegian Medicines Agency, Norway", "Jason Scott, Plymouth Hospitals NHS Trust, United Kingdom", "Anoop Shah, University College London, United Kingdom", "Line Silsand, Universitetssykehuset i Nord-Norge, Norway", "Trine Strand, Oslo Universitetssykehus (OUS), Norway", "Norwegian Review Summary, Nasjonal IKT HF, Norway", "Andreas Sundstrom, Capio S:t Gorans Hospital, Sweden", "John Taylor, NEHTA, Australia", "Rowan Thomas, St. Vincent's Hospital Melbourne, Australia", "Richard Townley-O'Neill, NEHTA, Australia (Editor)", "Guri Tømmervåg, DIPS AS, Norway", "Gro-Hilde Ulriksen, Norwegian center for ehealthresearch, Norway", "John Tore Valand, Helse Bergen, Norway (openEHR Editor)", "Pelle Viana Lindén, Capio, Sweden", "Kylie Young, The Royal Australian College of General Practitioners, Australia">
	other_details = <
		["licence"] = <"This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/3.0/.">
		["custodian_organisation"] = <"openEHR Foundation">
		["references"] = <"ISO 11238:2018, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated information on substances. Available from: https://www.iso.org/standard/69697.html.

ISO 11239:2012, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated information on pharmaceutical dose forms, units of presentation, routes of administration and packaging. Available from: https://www.iso.org/standard/55032.html.

ISO 11240:2012, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of units of measurement. Available from: https://www.iso.org/standard/55033.html.

ISO 11616:2017, Health informatics -- Identification of medicinal products -- Data elements and structures for unique identification and exchange of regulated pharmaceutical product information. Available from: https://www.iso.org/standard/70044.html.

ISO 11615:2017, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated medicinal product information. Available from: https://www.iso.org/standard/70150.html.

FHIR Resource Medication, HL7 [Internet]. Available at: https://www.hl7.org/fhir/medication.html (Accessed 12 April 2018)">
		["original_namespace"] = <"org.openehr">
		["original_publisher"] = <"openEHR Foundation">
		["custodian_namespace"] = <"org.openehr">
		["MD5-CAM-1.0.1"] = <"89BA41E6CD217F7E2639D05A6B02465C">
		["build_uid"] = <"20797e3d-bdcd-4134-b39a-a923abbb968a">
		["revision"] = <"2.0.1">
	>

definition
	CLUSTER[at0000] occurrences matches {0..1} matches {    -- Medication details
		items cardinality matches {1..*; unordered} matches {
			ELEMENT[at0132] occurrences matches {0..1} matches {    -- Name
				value matches {
					DV_TEXT matches {*}
				}
			}
			ELEMENT[at0071] occurrences matches {0..*} matches {    -- Form
				value matches {
					DV_TEXT matches {*}
				}
			}
			ELEMENT[at0142] occurrences matches {0..1} matches {    -- Category
				value matches {
					DV_CODED_TEXT matches {
						defining_code matches {
							[local::
							at0143,    -- Ad-hoc mixture
							at0146,    -- Ingredient
							at0144,    -- Multi-ingredient product
							at0145,    -- Single-ingredient product
							at0001]    -- Combination product
						}
					}
					DV_TEXT matches {*}
				}
			}
			CLUSTER[at0152] occurrences matches {0..1} matches {    -- Strength (presentation)
				items cardinality matches {1..*; unordered} matches {
					ELEMENT[at0153] matches {    -- Strength numerator
						value matches {
							DV_QUANTITY matches {*}
						}
					}
					ELEMENT[at0157] matches {    -- Strength denominator
						value matches {
							DV_QUANTITY matches {*}
						}
					}
				}
			}
			ELEMENT[at0115] occurrences matches {0..1} matches {    -- Strength (concentration)
				value matches {
					DV_QUANTITY matches {*}
				}
			}
			ELEMENT[at0151] occurrences matches {0..1} matches {    -- Manufacturer
				value matches {
					DV_TEXT matches {*}
				}
			}
			ELEMENT[at0150] occurrences matches {0..*} matches {    -- Batch ID
				value matches {
					DV_TEXT matches {*}
					DV_IDENTIFIER matches {*}
				}
			}
			ELEMENT[at0003] occurrences matches {0..1} matches {    -- Expiry
				value matches {
					DV_DATE_TIME matches {*}
				}
			}
			allow_archetype CLUSTER[at0138] occurrences matches {0..*} matches {    -- Constituent
				include
					archetype_id/value matches {/openEHR-EHR-CLUSTER\.medication(-[a-zA-Z0-9_]+)*\.v1|openEHR-EHR-CLUSTER\.medication(-[a-zA-Z0-9_]+)*\.v2/}
			}
			ELEMENT[at0139] occurrences matches {0..1} matches {    -- Amount
				value matches {
					DV_QUANTITY matches {*}
				}
			}
			ELEMENT[at0148] occurrences matches {0..1} matches {    -- Alternate amount
				value matches {
					DV_QUANTITY matches {*}
				}
			}
			ELEMENT[at0127] occurrences matches {0..1} matches {    -- Role
				value matches {
					DV_CODED_TEXT matches {
						defining_code matches {
							[local::
							at0080,    -- Therapeutic
							at0083,    -- Adjuvant
							at0084]    -- Excipient
						}
					}
					DV_TEXT matches {*}
				}
			}
			ELEMENT[at0133] occurrences matches {0..1} matches {    -- Description
				value matches {
					DV_TEXT matches {*}
				}
			}
			allow_archetype CLUSTER[at0141] occurrences matches {0..*} matches {    -- Structured details
				include
					archetype_id/value matches {/.*/}
			}
		}
	}


ontology
	term_definitions = <
		["en"] = <
			items = <
				["at0000"] = <
					text = <"Medication details">
					description = <"Details about a medication or component of a medication, including strength, form and details of any specific constituents.">
				>
				["at0001"] = <
					text = <"Combination product">
					description = <"The medication or medication component consists of a number of separate products which are pre-packaged by the manufacturer, for example Canesten Combi.">
				>
				["at0003"] = <
					text = <"Expiry">
					description = <"The expiry date and/or time of the medication or medication component, as given by the manufacturer or individual preparing the mixture.">
					comment = <"Any other form of expiry date, such as time from production or depending on storage environment, can be inserted using a specific CLUSTER archetype in the Substance Details slot or added as part of the Description.
 For example: '2017-05-23'.">
				>
				["at0071"] = <
					text = <"Form">
					description = <"The formulation or presentation of the medication or medication component.">
					comment = <"For example: 'tablet', 'capsule', 'cream', 'infusion fluid' or 'inhalation powder'. Coding of the form with a terminology is preferred, where possible. Medicines catalogues may differentiate between administrable form 'solution for injection' and product form 'powder for solution for injection'. The recorded form will depend on the exact context of use but administrable form is likely to be used in most instances.">
				>
				["at0080"] = <
					text = <"Therapeutic">
					description = <"Constituent that alone or in combination with one or more other ingredients is considered to fulfil the intended activity of a medicinal product.">
				>
				["at0083"] = <
					text = <"Adjuvant">
					description = <"Constituent whose primary function is to modify the activity of an active constituent. An adjuvant constituent itself may or may not be therapeutically active.">
				>
				["at0084"] = <
					text = <"Excipient">
					description = <"Constituent that is inert in relation to the intended activity of the medicinal product.">
				>
				["at0115"] = <
					text = <"Strength (concentration)">
					description = <"The strength of the medication or medication component, as a concentration.">
					comment = <"This element is used for liquid or semisolid medications, or medications intended to be diluted in a liquid before administration. For example: '10 mg/ml', '20 mg/g', '5 %', '10,000 SQ-U/ml'. If the 'Strength (presentation)' cluster is used, this element becomes redundant.">
				>
				["at0127"] = <
					text = <"Role">
					description = <"The role of the medication or medication component within a mixture.">
				>
				["at0132"] = <
					text = <"Name">
					description = <"The name of the medication or medication component.">
					comment = <"For example: 'Zinacef 750 mg powder' or 'cefuroxim'. This item should be coded if possible, using for example, RxNorm, DM+D, Australian Medicines Terminology or FEST. Usage of this element will vary according to context of use. This element may be omitted where the name of the medication is recorded in the parent INSTRUCTION or ACTION archetype, and this archetype is only used to record that the form must be or was 'liquid'.">
				>
				["at0133"] = <
					text = <"Description">
					description = <"Narrative description of the medication or medication component where it is not possible to describe this fully using structured elements.">
				>
				["at0138"] = <
					text = <"Constituent">
					description = <"Details of an ingredient or product used to make up a mixed pack, preparation or infusion.">
					comment = <"This slot is intended to be used to add details about constituents of the medication or medication component, using nested instances of this archetype. This is not normally required other than where a mixture is being described.">
				>
				["at0139"] = <
					text = <"Amount">
					description = <"The amount of medication or medication component.">
					comment = <"For example: '1 ml', '1.5 mg', '1000 ml'.">
				>
				["at0141"] = <
					text = <"Structured details">
					description = <"Additional details about the medication or medication component.">
					comment = <"For example: detailed information about the drug class or intended routes, or additional expiry information.">
				>
				["at0142"] = <
					text = <"Category">
					description = <"The category of the medication or medication component, with regard to manufacturing or preparation, and the number of ingredients.">
					comment = <"For example: 'Paracetamol/codeine' is a Multi-ingredient product, while 'Morphine 60 mg + Haloperidol 2 mg + Midazolam 5 mg' is an Ad-hoc mixture, whose composition is fully specified within the order.">
				>
				["at0143"] = <
					text = <"Ad-hoc mixture">
					description = <"The medication or medication component is composed of a mixture of ingredients specified within the order. These are typically prepared by pharmacy or ward personnel to suit individual patients.">
				>
				["at0144"] = <
					text = <"Multi-ingredient product">
					description = <"The medication or medication component consists of a number of active ingredients which are pre-combined into a single form such as a tablet, cream or powder by the manufacturer, for example Paracetamol/codeine.">
				>
				["at0145"] = <
					text = <"Single-ingredient product">
					description = <"The medication or medication component is a manufactured product containing a single active ingredient.">
				>
				["at0146"] = <
					text = <"Ingredient">
					description = <"The medication or medication component is an individual ingredient of the medication. This term is used when the archetype is nested within a parent instance of itself, to describe the individual ingredients of a medication.">
				>
				["at0148"] = <
					text = <"Alternate amount">
					description = <"An equivalent representation of the amount of the medication or medication component.">
					comment = <"For example: for a medication with a strength of '5 mg/ml' and where the Amount is '1 ml', and the value recorded in this data element would be '5 mg'.">
				>
				["at0150"] = <
					text = <"Batch ID">
					description = <"The identifier assigned to the production batch by the manufacturer during production.">
				>
				["at0151"] = <
					text = <"Manufacturer">
					description = <"The manufacturer of the medication or medication component.">
					comment = <"For example: 'Abbott'.">
				>
				["at0152"] = <
					text = <"Strength (presentation)">
					description = <"The strength of the medication or medication component, expressed as a ratio.">
					comment = <"In some cases, as for liquid or semisolid medications, the denominator of the strength ratio is a physical quantity, for example 2 mg/5 ml. In some of these cases the denominator also reflects the actual volume of the component: 5 ml in the previous example. In this case the 'Strength (concentration)' would be 0.4 mg/ml. In other cases, where the strength involves a denominator which is not a physical quantity, for example 4 mg/tablet, the denominator is expressed as a unitary value '1' with a unit of 'tablet'. This arrangement was chosen to align with the approach adopted by the ISO IDMP standard for medication catalogues. If the 'Strength (concentration)' element is used, this cluster becomes redundant.">
				>
				["at0153"] = <
					text = <"Strength numerator">
					description = <"The numerator of the strength fraction.">
					comment = <"For example: For a presentation strength of '300 µg/0.3 ml', the strength numerator is '300 µg'. For a presentation strength of '100 mg/tablet', the strength numerator value is '100 mg'.">
				>
				["at0157"] = <
					text = <"Strength denominator">
					description = <"The denominator of the strength fraction.">
					comment = <"For example: For a presentation strength of '300 µg/0.3 ml', the strength denominator value is '0.3 ml'. For a presentation strength of '100 mg/tablet', the strength denominator value is '1 tablet'.">
				>
			>
		>
		["nb"] = <
			items = <
				["at0000"] = <
					text = <"Legemiddeldetaljer">
					description = <"Detaljer om et legemiddel eller en komponent av et legemiddel, inkludert detaljer om spesifikke bestanddeler.">
				>
				["at0001"] = <
					text = <"Kombinasjonspakning">
					description = <"Legemiddelet eller legemiddelkomponenten består av flere separate produkter som er forhåndspakket av produsenten, for eksempel Canesten vaginalkapsel + krem.">
				>
				["at0003"] = <
					text = <"Holdbarhetsdato">
					description = <"Tidspunktet for når legemiddelet ikke lenger skal benyttes, som angitt av produsenten eller den som tilbereder blandingen.">
					comment = <"For eksempel \"2017-05-23\". Andre former for utløpsdatoer som må dokumenteres, som for eksempel tid fra produksjonstidspunktet eller avhengighet av lagringsforhold, kan legges til som en spesifikk CLUSTER-arketype eller som en kommentar.">
				>
				["at0071"] = <
					text = <"Form">
					description = <"Formulering eller form av legemiddelet.">
					comment = <"For eksempel \"tablett\", \"kapsel\", \"krem\", infusjonsvæske\". Koding av legemiddelformen med en terminologi foretrekkes der det er mulig. Legemiddelkataloger differensierer i noen tilfeller mellom administrerbar form, \"injeksjonsvæske\", og formen slik den er i pakken, \"pulver til injeksjonsvæske\". Formen som skal registreres kommer an på den eksakte brukssammenhengen, men i de fleste tilfeller vil administrerbar form være mest aktuelt.">
				>
				["at0080"] = <
					text = <"Terapeutisk">
					description = <"Bestanddel som alene eller i kombinasjon med en eller flere andre ingredienser oppfyller den tiltenkte aktiviteten av legemiddelet.">
				>
				["at0083"] = <
					text = <"Adjuvans">
					description = <"Bestanddel hvis hovedfunksjon er å modifisere aktiviteten av en aktiv bestanddel. En adjuvans kan i seg selv være enten aktiv eller inaktiv.">
				>
				["at0084"] = <
					text = <"Hjelpestoff">
					description = <"Bestanddel som er inaktiv i forhold til den tiltenkte aktiviteten av legemiddelet.">
				>
				["at0115"] = <
					text = <"Styrke (konsentrasjon)">
					description = <"Styrken av legemiddelet eller legemiddelkomponenten, angitt som konsentrasjon.">
					comment = <"Dette elementet brukes for flytende eller halvfaste legemidler, eller legemidler som skal blandes ut til å bli flytende før administrering. For eksempel \"10 mg/ml\", \"20 mg/g\", \"5 %\" eller \"10 000 SQ-U/ml\". Dersom clusteret \"Styrke (presentasjon)\" brukes, er dette clusteret overflødig.">
				>
				["at0127"] = <
					text = <"Rolle">
					description = <"Legemiddelet eller legemiddelkomponentens rolle i en blanding eller infusjon.">
				>
				["at0132"] = <
					text = <"Navn">
					description = <"Navnet på legemiddelet eller legemiddelkomponenten.">
					comment = <"For eksempel \"Zinacef 750 mg pulver til infusjonsvæske\" eller \"cefuroxim\". Dette elementet bør kodes om mulig, for eksempel med FEST. Bruk av dette elementet vil variere med brukssammenhengen. For eksempel vil elementet ikke brukes dersom legemiddelnavnet er registrert i den overordnede INSTRUCTION- eller ACTION-arketypen, og denne arketypen kun brukes for å registrere at legemiddelformen må være eller var \"væske\".">
				>
				["at0133"] = <
					text = <"Beskrivelse">
					description = <"Fritekstbeskrivelse av legemiddelet eller legemiddelkomponenten, der det ikke lar seg gjøre å beskrive dette fullstendig ved hjelp av strukturerte elementer.">
				>
				["at0138"] = <
					text = <"Bestanddel">
					description = <"Detaljer om en ingrediens eller produkt som brukes til å lage en blandet pakning, preparat eller infusjon.">
					comment = <"Dette SLOTet benyttes når arketypen nøstes inni en overordnet instans av den samme arketypen, for å beskrive de individuelle bestanddelene av et legemiddel. Dette er som regel ikke nødvendig, annet enn der en beskriver en blanding.">
				>
				["at0139"] = <
					text = <"Mengde">
					description = <"Mengden av legemiddelet eller legemiddelkomponenten.">
					comment = <"For eksempel \"1 ml\", \"1,5 mg\" eller \"1000 ml\".">
				>
				["at0141"] = <
					text = <"Strukturerte detaljer">
					description = <"Ytterligere detaljer om legemiddelet eller legemiddelkomponenten.">
					comment = <"For eksempel detaljert informasjon om legemiddelklassen, tiltenkte administrasjonsveier, eller ytterligere informasjon om holdbarhet.">
				>
				["at0142"] = <
					text = <"Kategori">
					description = <"Legemiddelet eller legemiddelkomponentens kategori med tanke på tilvirkning eller tilberedning, og antall ingredienser.">
					comment = <"For eksempel er Paralgin Forte et kombinasjonsprodukt, mens \"Morfin 60 mg + Haloperidol 2 mg + Midazolam 5 mg\" er en magistrellforskrevet blanding, som er fullt spesifisert i ordineringen.">
				>
				["at0143"] = <
					text = <"Magistrellforskrevet blanding">
					description = <"Legemiddelet eller legemiddelkomponenten er en sammensatt blanding av ingredienser som er spesifisert i en ordinering. Disse tillages typisk av apotek- eller sengepostpersonell for individuelle pasienter.">
				>
				["at0144"] = <
					text = <"Kombinasjonsprodukt">
					description = <"Komponenten består av flere aktive ingredienser som er satt sammen til én form som en tablett, krem eller pulver av produsenten. For eksempel Paralgin Forte.">
				>
				["at0145"] = <
					text = <"Produkt som inneholder én aktiv ingrediens">
					description = <"Legemiddelet eller legemiddelkomponenten er et fabrikkframstilt produkt som kun har én aktiv ingrediens.">
				>
				["at0146"] = <
					text = <"Bestanddel">
					description = <"Legemiddelkomponenten er en ingrediens i legemiddelet. Denne termen benyttes når arketypen nøstes inni en overordnet instans av den samme arketypen, for å beskrive de individuelle ingrediensene i et legemiddel.">
				>
				["at0148"] = <
					text = <"Alternativ mengde">
					description = <"En alternativ men tilsvarende angivelse av mengden legemiddel eller legemiddelkomponent.">
					comment = <"For eksempel dersom et legemiddel har styrke 5 mg/ml og mengden er \"1 ml\", vil verdien som registreres i dette dataelementet være \"5 mg\".">
				>
				["at0150"] = <
					text = <"Batch-ID">
					description = <"Identifikatoren tilordnet av produsenten for å identifisere produksjons-batchen for produktet.">
				>
				["at0151"] = <
					text = <"Produsent">
					description = <"Produsenten av komponenten.">
					comment = <"For eksempel \"Abbott\".">
				>
				["at0152"] = <
					text = <"Styrke (presentasjon)">
					description = <"Styrken av legemiddelet eller legemiddelkomponenten, angitt som en brøk.">
					comment = <"I noen tilfeller, som for flytende eller halvfaste legemidler, er nevneren i styrkebrøken en fysisk størrelse, for eksempel 2 mg/5 ml. I noen av disse tilfellene reflekterer nevneren også det faktiske volumet av komponenten: For det forrige eksempelet 5 ml. I dette tilfellet ville \"Styrke (konsentrasjon)\" vært 0,4 mg/ml. I andre tilfeller, der styrken involverer en nevner som ikke er en fysisk størrelse, for eksempel 4 mg/tablett, uttrykkes nevneren som verdien \"1\", med enheten \"tablett\". Dette mønsteret ble valgt som en tilpasning til ISO IDMP-standarden. For eksempel 4 mg/tablett, 2 mg/5 ml, 100 mg/dose. Dersom elementet \"Styrke (konsentrasjon)\" brukes, er dette clusteret overflødig.">
				>
				["at0153"] = <
					text = <"Styrketeller">
					description = <"Telleren i styrkebrøken.">
					comment = <"For eksempel: For en presentasjonsstyrke på \"300 µg/0,3 ml\", er Styrketeller \"300 µg\". For en presentasjonsstyrke på \"100 mg/tablett\", er Styrketeller \"100 mg\".">
				>
				["at0157"] = <
					text = <"Styrkenevner">
					description = <"Nevneren i styrkebrøken.">
					comment = <"For eksempel: For en presentasjonsstyrke på \"300 µg/0,3 ml\", er Styrkenevner \"0,3 ml\". For en presentasjonsstyrke på \"100 mg/tablett\", er Styrkenevner \"1 tablett\".">
				>
			>
		>
		["pt"] = <
			items = <
				["at0000"] = <
					text = <"*Medication details (en)">
					description = <"*Details about a medication or component of a medication, including strength, form, and details of any specific constituents.(en)">
				>
				["at0001"] = <
					text = <"*Combination pack(en)">
					description = <"*The component consists of a number of separate products which are pre-packaged by the manufacturer.(en)">
				>
				["at0003"] = <
					text = <"*Expiry(en)">
					description = <"*The expiry date and/or time of the medication or medication component, as given by the manufacturer or individual preparing the mixture.(en)">
					comment = <"*Any other form of expiry date, such as time from production or depending on storage environment, can be inserted using a specific CLUSTER archetype in the Substance Details slot or added as part of the Description.
 For example: '2017-05-23'.(en)">
				>
				["at0071"] = <
					text = <"*Form(en)">
					description = <"*The formulation or presentation of the medication or medication component.(en)">
					comment = <"*For example: 'tablet', 'capsule', 'cream', 'infusion fluid' or 'inhalation powder'. Coding of the form with a terminology is preferred, where possible. Medicines catalogues may differentiate between administrable form 'solution for injection' and product form 'powder for solution for injection'. The recorded form will depend on the exact context of use but administrable form is likely to be used in most instances.(en)">
				>
				["at0080"] = <
					text = <"Terapêutico">
					description = <"Este elemento químico tem um efeito conhecido e considerado como positivo.">
				>
				["at0083"] = <
					text = <"Coadjuvante">
					description = <"Este elemento químico é ativo mas apoia o efeito terapêutico de outro ingrediente.">
				>
				["at0084"] = <
					text = <"Diluente">
					description = <"Diluente inerte.">
				>
				["at0115"] = <
					text = <"*Strength (concentration)(en)">
					description = <"*The strength of the medication or medication component, as a concentration.(en)">
					comment = <"*This element is used for liquid or semisolid medications, or medications intended to be diluted in a liquid before administration. For example: '10 mg/ml', '20 mg/g', '5 %', '10,000 SQ-U/ml'. If the 'Strength (presentation)' cluster is used, this element becomes redundant. (en)">
				>
				["at0127"] = <
					text = <"*Role(en)">
					description = <"*The role of the constituent within the mixture or infusion.(en)">
				>
				["at0132"] = <
					text = <"*Name(en)">
					description = <"*The name of the medication or medication component.(en)">
					comment = <"*For example: 'Zinacef 750 mg powder' or 'cefuroxim'. This item should be coded if possible, using for example, RxNorm, DM+D, Australian Medicines Terminology or FEST. Usage of this element will vary according to context of use. This element may be omitted where the name of the medication is recorded in the parent INSTRUCTION or ACTION archetype, and this archetype is only used to record that the form must be or was 'liquid'.(en)">
				>
				["at0133"] = <
					text = <"*Description(en)">
					description = <"*Narrative description of the medication or medication component where it is not possible to describe this fully using structured elements.(en)">
				>
				["at0138"] = <
					text = <"*Constituent details(en)">
					description = <"*Details of the constituent.(en)">
				>
				["at0139"] = <
					text = <"*Amount(en)">
					description = <"*The amount of medication or medication component. (en)">
					comment = <"*For example: '1 ml', '1.5 mg', '1000 ml'.  (en)">
				>
				["at0141"] = <
					text = <"*Structured details(en)">
					description = <"*Additional details about the medication or medication component.(en)">
					comment = <"*For example: detailed information about the drug class or intended routes, or additional expiry information.(en)">
				>
				["at0142"] = <
					text = <"*Category(en)">
					description = <"*The category of the medication or medication component, with regard to manufacturing or preparation, and the number of ingredients.(en)">
					comment = <"*For example: 'Paracetamol/codeine' is a Multi-ingredient product, while 'Morphine 60 mg + Haloperidol 2 mg + Midazolam 5 mg' is an Ad-hoc mixture, whose composition is fully specified within the order.(en)">
				>
				["at0143"] = <
					text = <"*Ad-hoc mixture(en)">
					description = <"*The component is composed of a mixture of ingredients specified within the order.(en)">
				>
				["at0144"] = <
					text = <"*Multi-ingredient product(en)">
					description = <"*The medication or medication component consists of a number of active ingredients which are pre-combined into a single form such as a tablet, cream or powder by the manufacturer, for example Paracetamol/codeine.(en)">
				>
				["at0145"] = <
					text = <"*Single-substance product(en)">
					description = <"*The component is a manufactured product containing a single ingredient.(en)">
				>
				["at0146"] = <
					text = <"*Ingredient(en)">
					description = <"*The medication or medication component is an individual ingredient of the medication. This term is used when the archetype is nested within a parent instance of itself, to describe the individual ingredients of a medication.(en)">
				>
				["at0148"] = <
					text = <"*Alternate amount(en)">
					description = <"*An equivalent representation of the amount of the medication or medication component. (en)">
					comment = <"*For example: for a medication with a strength of '5 mg/ml' and where the Amount is '1 ml', and the value recorded in this data element would be '5 mg'. (en)">
				>
				["at0150"] = <
					text = <"*Batch ID(en)">
					description = <"*The identifier assigned to the batch of medications by the manufacturer during production.(en)">
				>
				["at0151"] = <
					text = <"*Manufacturer(en)">
					description = <"*The manufacturer of the component.(en)">
					comment = <"*For example: 'Abbott'.(en)">
				>
				["at0152"] = <
					text = <"*Strength (presentation)(en)">
					description = <"*The strength of the medication or medication component, expressed as a ratio.(en)">
					comment = <"*In some cases, as for liquid or semisolid medications, the denominator of the strength ratio is a physical quantity, for example 2 mg/5 ml. In some of these cases the denominator also reflects the actual volume of the component: 5 ml in the previous example. In this case the 'Strength (concentration)' would be 0.4 mg/ml. In other cases, where the strength involves a denominator which is not a physical quantity, for example 4 mg/tablet, the denominator is expressed as a unitary value '1' with a unit of '1', and 'tablet' is carried in the 'Unit of presentation' element. This arrangement was chosen to align with the approach adopted by the ISO IDMP standard for medication catalogues. If the 'Strength (concentration)' element is used, this cluster becomes redundant. (en)">
				>
				["at0153"] = <
					text = <"*Strength numerator(en)">
					description = <"*The numerator of the strength fraction. (en)">
					comment = <"*For example: For a presentation strength of '300 µg/0.3 ml', the strength numerator is '300 µg'. For a presentation strength of '100 mg/tablet', the strength numerator value is '100 mg'. (en)">
				>
				["at0157"] = <
					text = <"*Strength denominator(en)">
					description = <"*The denominator of the strength fraction. (en)">
					comment = <"*For example: For a presentation strength of '300 µg/0.3 ml', the strength denominator value is '0.3 ml'. For a presentation strength of '100 mg/tablet', the strength denominator value is '1 tablet'. (en)">
				>
			>
		>
		["de"] = <
			items = <
				["at0000"] = <
					text = <"Arzneimittel">
					description = <"Angaben über ein Arzneimittel oder eine Arzneimittelkomponente, einschließlich der Wirkstärke, der Darreichungsform und Informationen über spezifische Bestandteile.">
				>
				["at0001"] = <
					text = <"Kombinationsprodukt">
					description = <"Das Arzneimittel oder die Arzneimittelkomponente besteht aus einer Reihe von separaten Produkten, die vom Hersteller vorverpackt werden, z.B. Canesten Combi.">
				>
				["at0003"] = <
					text = <"Verfallsdatum">
					description = <"Das Verfallsdatum und/oder die Verfallszeit des Arzneimittels oder der Arzneimittelkomponente. Diese Angabe wird vom Hersteller oder einer Person während der Mixtur-Zubereitung gemacht.">
					comment = <"Jegliche andere Formen des Verfallsdatums, wie z.B. die Zeit ab Produktion oder Abhängigkeiten von der Lagerumgebung, können in einem spezifischen CLUSTER-Archetyp aufgenommen werden. Darüber hinaus können diese Angaben auch in einem SLOT, der Details über die Substanz dokumentiert, oder als Teil einer Beschreibung erfasst werden. Zum Beispiel: \"23.05.2017\".">
				>
				["at0071"] = <
					text = <"Darreichungsform">
					description = <"Die Zubereitung oder die Darstellung eines Arzneimittels oder einer Arzneimittelkomponente.">
					comment = <"Zum Beispiel: \"Tablette\", \"Kapsel\", \"Creme\", \"Infusionslösung\" oder \"Inhalationspulver\". Die Codierung der Darreichungsform mit einer Terminologie wird, sofern dies möglich ist, bevorzugt. Die Arzneimittelkataloge können zwischen der Form zur Verabreichung \"Injektionslösung\" und der Form des Produktes \"Pulver zur Zubereitung der Injektionslösung\" unterscheiden. Die dargestellte Form hängt vom Kontext der Anwendung ab. Es wird meist jedoch die Verabreichungsform verwendet.">
				>
				["at0080"] = <
					text = <"Wirkstoff">
					description = <"Bestandteil, der allein oder in Kombination mit einem oder mehreren anderen Inhaltsstoffen die beabsichtigte Wirkung eines Arzneimittels erfüllt.">
				>
				["at0083"] = <
					text = <"Hilfsstoff">
					description = <"Ein Bestandteil mit der primären Funktion, die Wirkung des aktiven Bestandteils zu verändern. Ein unterstützender (adjuvant) Bestandteil kann selbst therapeutisch wirksam sein, muss es aber nicht.">
				>
				["at0084"] = <
					text = <"Sonstiger Bestandteil">
					description = <"Bestandteil, der in Bezug auf die beabsichtigte Wirkung des Arzneimittels unbeteiligt ist.">
				>
				["at0115"] = <
					text = <"Wirkstoffkonzentration">
					description = <"Die Wirkstärke eines Arzneimittels oder einer Arzneimittelkomponente als Konzentration.">
					comment = <"Dieses Element wird für Flüssigkeiten, halbfesten Arzneimitteln oder Arzneimitteln, die vor der Verabreichung in einer Flüssigkeit gelöst werden müssen, verwendet. Zum Beispiel: \"10 mg/ml\", \"20 mg/g\", \"5 %\", \"10,000 SQ-U/ml\". Wird der Cluster \"Wirkstärke (Darreichungsform)\" verwendet, wird dieses Element überflüssig.">
				>
				["at0127"] = <
					text = <"Funktion">
					description = <"Die Funktion eines Arzneimittels oder einer Arzneimittelkomponente innerhalb einer Mixtur.">
				>
				["at0132"] = <
					text = <"Name">
					description = <"Der Name des Arzneimittels oder der Arzneimittelkomponente.">
					comment = <"Zum Beispiel: \"Zinacef 750 mg Puder\" oder \"Cefuroxim\". Dieses Item sollte möglichst codiert werden, z.B. mittels RxNorm, DM+D, Australian Medicines Terminology oder FEST. Die Verwendung dieses Elements variiert je nach Anwendungskontext. Dieses Element kann weggelassen werden, wenn der Name des Arzneimittels in dem übergeordneten INSTRUCTION- oder ACTION-Archetyp vorhanden ist, und dieser Archetyp nur zur Darstellung der Darreichungsform genutzt wird, z.B. \"Flüssigkeit\".">
				>
				["at0133"] = <
					text = <"Beschreibung">
					description = <"Eine Möglichkeit zur Beschreibung des Arzneimittels oder der Arzneimittelkomponente, wenn dies nicht mit vollständig strukturierten Elementen möglich war.">
				>
				["at0138"] = <
					text = <"Bestandteil">
					description = <"Angaben zu einem Inhaltsstoff oder Produkt, das zur Herstellung einer Mischpackung, eines Präparats oder einer Infusion verwendet wird.">
					comment = <"Dieser Slot ist dazu gedacht, dem Archetyp Details über Bestandteile des Arzneimittels oder der Arzneimittelkomponente unter Verwendung verschachtelter Instanzen hinzuzufügen. Dies ist in der Regel nur dann erforderlich, wenn eine Mixtur beschrieben wird.">
				>
				["at0139"] = <
					text = <"Menge">
					description = <"Die Menge des Arzneimittels oder der Arzneimittelkomponente.">
					comment = <"Zum Beispiel: \"1 ml\", \"1,5 mg\", \"1000 ml\".">
				>
				["at0141"] = <
					text = <"Strukturierte Angaben">
					description = <"Zusätzliche Angaben über das Arzneimittel oder die Arzneimittelkomponente.">
					comment = <"Zum Beispiel: Detaillierte Informationen über Wirkstoffgruppe oder vorgesehene Verabreichungswege, oder zusätzliche Informationen zum Verfallsdatum.">
				>
				["at0142"] = <
					text = <"Kategorie">
					description = <"Die Kategorie des Arzneimittels oder der Arzneimittelkomponente, hinsichtlich der Herstellung oder Zubereitung und der Anzahl der Inhaltsstoffe.">
					comment = <"Zum Beispiel: \"Paracetamol/Codein\" ist ein Produkt mit mehreren Inhaltsstoffen, im Gegensatz dazu ist \"Morphin 60 mg + Haloperidol 2 mg + Midazolam 5 mg\" eine Ad-hoc-Mixtur, deren Zusammensetzung innerhalb der Verordnung spezifiziert wird.">
				>
				["at0143"] = <
					text = <"Ad-hoc Mixtur">
					description = <"Das Arzneimittel oder die Arzneimittelkomponente besteht aus einer Mischung von Inhaltsstoffen, die in der Verordnung angegeben sind. Diese werden in der Regel von Apotheken- oder Stationspersonal individuell für den Patienten zubereitet.">
				>
				["at0144"] = <
					text = <"Produkt mit meheren Inhaltsstoffen">
					description = <"Das Arzneimittel oder die Arzneimittelkomponente besteht aus einer Reihe von Wirkstoffen, die vom Hersteller in einer Darreichungsform, wie z.B. als eine Tablette, Creme oder ein Pulver, zusammengesetzt werden. Ein Beispiel hierfür ist Paracetamol/Codein.">
				>
				["at0145"] = <
					text = <"Produkt mit einem Inhaltsstoff">
					description = <"Das Arzneimittel oder die Arzneimittelkomponente ist ein hergestelltes Produkt, das einen einzigen Wirkstoff enthält.">
				>
				["at0146"] = <
					text = <"Inhaltsstoff">
					description = <"Das Arzneimittel oder die Arzneimittelkomponente ist ein einzelner Inhaltsstoff des Arzneimittels. Dieser Begriff wird verwendet, wenn der Archetyp innerhalb einer übergeordneten Instanz seines eigenen Archetyps verschachtelt ist, um die einzelnen Bestandteile eines Arzneimittels zu beschreiben.">
				>
				["at0148"] = <
					text = <"Alternative Menge">
					description = <"Der Wert einer äquivalenten Darstellung der Menge des Arzneimittels oder der Arzneimittelkomponente.">
					comment = <"Beispiel: Für ein Arzneimittel mit einer Wirkstoffkonzentration von \"5 mg/ml\" und einer Menge von \"1 ml\" und der in diesem Datenelement aufgezeichnete Wert wäre \"5 mg\".">
				>
				["at0150"] = <
					text = <"Batch ID">
					description = <"Die Kennung der Produktionscharge, die vom Hersteller während der Produktion zugewiesen wird.">
				>
				["at0151"] = <
					text = <"Hersteller">
					description = <"Der Hersteller des Arzneimittels oder der Arzneimittelkomponente.">
					comment = <"Zum Beispiel: \"Abbott\".">
				>
				["at0152"] = <
					text = <"Wirkstärke (Darreichungsform)">
					description = <"Die Wirkstärke des Arzneimittels oder der Arzneimittelkomponente, ausgedrückt als Verhältniszahl.">
					comment = <"In einigen Fällen, wie bei flüssigen oder halbfesten Arzneimitteln, ist der Nenner des Stärkeverhältnisses eine physikalische Größe, zum Beispiel 2 mg/5 ml. In einigen dieser Fälle spiegelt der Nenner auch das tatsächliche Volumen der Komponente wider: 5 ml im vorherigen Beispiel. In diesem Fall würde die \"Wirkstoffkonzentration\" 0,4 mg/ml betragen. In anderen Fällen, wenn die Stärke einen Nenner betrifft, der keine physikalische Größe ist, z.B. 4 mg/Tablette, wird der Nenner als einheitlicher Wert \"1\" mit einer Einheit \"1\" ausgedrückt, und \"Tablette\" wird im Element \"Einheit der Darreichungsform\" geführt. Diese Regelung wurde gewählt, um dem Ansatz der ISO IDMP-Norm für Medikamentenkataloge gerecht zu werden. Wird das Element \"Wirkstoffkonzentration\" verwendet, wird dieser Cluster überflüssig.">
				>
				["at0153"] = <
					text = <"Wirkstärke (Zähler)">
					description = <"Der Wert des Zählers des Wirkstärkeanteils.">
					comment = <"Zum Beispiel: Lautet die Wirkstärke (Darreichungsform) \"300 µg/0,3 ml\", so beträgt die Wirkstärke (Zähler) \"300 µg\". Bei einer Wirkstärke (Darreichungsform) von \"100 mg/Tablette\" ist der Wirkstärke-Zähler \"100 mg\".">
				>
				["at0157"] = <
					text = <"Wirkstärke (Nenner)">
					description = <"Der Wert des Nenners des Wirkstärkeanteils.">
					comment = <"Zum Beispiel: Der Wert des Nenners der Wirkstärke (Darreichungsform) \"300 µg/0,3 ml\" ist \"0,3 ml\". Der Wert des Nenners der Wirkstärke \"100 mg/Tablette\" ist \"1 Tablette\".">
				>
			>
		>
		["nl"] = <
			items = <
				["at0000"] = <
					text = <"*Medication details (en)">
					description = <"Gegevens over een medicament of onderdeel van een medicament, inclusief dosis, vorm en details over een specifiek bestandsdeel.">
				>
				["at0001"] = <
					text = <"Combinatie product">
					description = <"Het medicament of medicatie bestanddeel bestaat uit een aantal onafhankelijke producten die voorverpakt zijn door de fabrikant, bijvoorbeeld 'Canesten Combi'.">
				>
				["at0003"] = <
					text = <"Houdbaarheid">
					description = <"De houdbaarheidsdatum en/of tijd van het medicament of medicatie bestanddeel, zoals bepaald door de fabrikant of het individu dat het mengsel bereidt.">
					comment = <"*Any other form of expiry date, such as time from production or depending on storage environment, can be inserted using a specific CLUSTER archetype in the Substance Details slot or added as part of the Description.
 For example: '2017-05-23'. (en)">
				>
				["at0071"] = <
					text = <"Vorm">
					description = <"De vorm waarin het medicament of medicatie bestandsdeel aangeboden wordt.">
					comment = <"Bijvoorbeeld: 'tablet', 'capsule', 'creme', 'infusie vloeistof' of 'inhalatie poeder'. Coderen van de vorm met een terminology verdient de voorkeur, indien mogelijk. Medicatie formularia kunnen onderscheid maken tussen vormen die toegediend kunnen worden: 'oplossing voor injectie' en productvormen: 'poeder voor oplossing voor injectie'. De vastgelegde vorm zal afhangen van de specifieke gebruikscontext maar toedienbare vorm zal waarschijnlijk het meest gebruikt worden.">
				>
				["at0080"] = <
					text = <"Therapeuticum">
					description = <"*Constituent that alone or in combination with one or more other ingredients is considered to fulfil the intended activity of a medicinal product. (en)">
				>
				["at0083"] = <
					text = <"Adjuvans">
					description = <"*Constituent whose primary function is to modify the activity of an active constituent. An adjuvant constituent itself may or may not be therapeutically active.">
				>
				["at0084"] = <
					text = <"*Excipient (en)">
					description = <"*Constituent that is inert in relation to the intended activity of the medicinal product. (en)">
				>
				["at0115"] = <
					text = <"Dosis (concentratie)">
					description = <"*The strength of the medication or medication component, as a concentration. (en)">
					comment = <"*This element is used for liquid or semisolid medications, or medications intended to be diluted in a liquid before administration. For example: '10 mg/ml', '20 mg/g', '5 %', '10,000 SQ-U/ml'. If the 'Strength (presentation)' cluster is used, this element becomes redundant. (en)">
				>
				["at0127"] = <
					text = <"Rol">
					description = <"De rol van het medicament of het medicatie bestanddeel in een mengsel.">
				>
				["at0132"] = <
					text = <"Naam">
					description = <"De naam van het medicament of medicatie bestandsdeel.">
					comment = <"Bijvoorbeeld: 'Zinacef 750mg poeder' of 'cefuroxim'. Dit veld dient, indien mogelijk, gecodeerd te worden met behulp van bijvoorbeeld RxNorm, DM+D, Autralian Medicines Terminology, FEST of de G-Standaard. Gebruik van dit veld zal verschillen per gebruikscontext. Dit element can overgeslagen worden wanneer de naam van het medicament vastgelegd is in het bovenliggende INSTRUCTION of ACTION archetype en dit archetype zelf alleen gebruikt wordt voor het vastleggen dat de vorm 'vloeibaar' is, of dient te zijn.">
				>
				["at0133"] = <
					text = <"Beschrijving">
					description = <"*Narrative description of the medication or medication component where it is not possible to describe this fully using structured elements. (en)">
				>
				["at0138"] = <
					text = <"Bestanddeel">
					description = <"Gegevens over een bestanddeel of product als onderdeel van een gemengde strip, bereiding of infusie.">
					comment = <"*This slot is intended to be used to add details about constituents of the medication or medication component, using nested instances of this archetype. This is not normally required other than where a mixture is being described. (en)">
				>
				["at0139"] = <
					text = <"Hoeveelheid">
					description = <"*The amount of medication or medication component. (en)">
					comment = <"*For example: '1 ml', '1.5 mg', '1000 ml'.  (en)">
				>
				["at0141"] = <
					text = <"*Structured details (en)">
					description = <"*Additional details about the medication or medication component. (en)">
					comment = <"*For example: detailed information about the drug class or intended routes, or additional expiry information. (en)">
				>
				["at0142"] = <
					text = <"Categorie">
					description = <"De categorie van het medicament of het medicatie bestandsdeel, gerelateerd aan fabricage of bereiding en het aantal bestandsdelen.">
					comment = <"Bijvoorbeeld: 'Paracetamol/codeïne' is een combinatiepreparaat, terwijl 'Morphine 60mg + Haloperidol 2 mg +Midazolam 5 mg' een ad-hoc mix is waarvan de samenstelling in het recept wordt beschreven.">
				>
				["at0143"] = <
					text = <"Ad-hoc mengsel">
					description = <"Het medicament of medicatie bestandsdeel bestaat uit een mengsel van bestanddelen vastgelegd in het recept. Deze worden normaal specifiek voor een patient bereidt door apotheek- of verpleegafdelingspersoneel.">
				>
				["at0144"] = <
					text = <"Samengesteld product">
					description = <"Het medicament of het medicatie bestanddeel bestaat uit een aantal actieve onderdelen die in enkele vorm zoals een table, creme of poeder, bereid zijn door de fabrikant, bijvoorbeeld 'Paracetamol/codeïne'.">
				>
				["at0145"] = <
					text = <"Enkelvoudig productie">
					description = <"Een medicament of medicatie bestanddeel is een gefabriceerd product dat een enkel actief bestanddeel bevat.">
				>
				["at0146"] = <
					text = <"Bestanddeel">
					description = <"Het medicament of het medicatie bestanddeel is een enkel bestanddeel van het medicament. Deze term wordt gebruikt wanneer het archetype onderdeel is van een 'parent instance' van zichzelf, voor het beschrijven van individuele bestanddelen van een medicament.">
				>
				["at0148"] = <
					text = <"Alternatieve hoeveelheid">
					description = <"*An equivalent representation of the amount of the medication or medication component. (en)">
					comment = <"*For example: for a medication with a strength of '5 mg/ml' and where the Amount is '1 ml', and the value recorded in this data element would be '5 mg'. (en)">
				>
				["at0150"] = <
					text = <"Batch ID">
					description = <"De identificatie toegewezen aan de productie batch door de fabrikant tijdens de productie. Ook wel partij-, lot- of chargenummer genoemd.">
				>
				["at0151"] = <
					text = <"Fabrikant">
					description = <"De fabrikant van het medicament of medicatie bestanddeel.">
					comment = <"Bijvoorbeeld: 'Abbott'.">
				>
				["at0152"] = <
					text = <"Dosis (presentatie)">
					description = <"De dosis van het medicament of medicatie bestanddeel, uitgedrukt als een ratio.">
					comment = <"*In some cases, as for liquid or semisolid medications, the denominator of the strength ratio is a physical quantity, for example 2 mg/5 ml. In some of these cases the denominator also reflects the actual volume of the component: 5 ml in the previous example. In this case the 'Strength (concentration)' would be 0.4 mg/ml. In other cases, where the strength involves a denominator which is not a physical quantity, for example 4 mg/tablet, the denominator is expressed as a unitary value '1' with a unit of '1', and 'tablet' is carried in the 'Unit of presentation' element. This arrangement was chosen to align with the approach adopted by the ISO IDMP standard for medication catalogues. If the 'Strength (concentration)' element is used, this cluster becomes redundant. (en)">
				>
				["at0153"] = <
					text = <"Dosis teller">
					description = <"*The numerator of the strength fraction. (en)">
					comment = <"*For example: For a presentation strength of '300 µg/0.3 ml', the strength numerator is '300 µg'. For a presentation strength of '100 mg/tablet', the strength numerator value is '100 mg'. (en)">
				>
				["at0157"] = <
					text = <"Dosis noemer">
					description = <"*The denominator of the strength fraction. (en)">
					comment = <"*For example: For a presentation strength of '300 µg/0.3 ml', the strength denominator value is '0.3 ml'. For a presentation strength of '100 mg/tablet', the strength denominator value is '1 tablet'. (en)">
				>
			>
		>
		["sv"] = <
			items = <
				["at0000"] = <
					text = <"*Medication details (en)">
					description = <"Detaljer om ett läkemedel eller en läkemedelskomponent, inkluderat styrka, form och detaljer för alla specifika beståndsdelar.">
				>
				["at0001"] = <
					text = <"Kombinationsprodukt">
					description = <"Läkemedlet eller läkemedelskomponenten består av ett antal separata produkter som förpackas av tillverkaren, till exempel Canesten Combi.">
				>
				["at0003"] = <
					text = <"Hållbarhetsdatum">
					description = <"Utgångsdatum och/eller tidpunkt för läkemedels- eller läkemedelskomponenten, enligt tillverkarens eller individens beredning av blandningen.">
					comment = <"Annan form av utgångsdatum, till exempel tid från produktion eller beroende på lagringsmiljö, kan infogas med en specifikt CLUSTER i substansdetaljer eller läggas till som en del av beskrivningen.
Till exempel: '2017-05-23'.">
				>
				["at0071"] = <
					text = <"Form">
					description = <"Formen eller presentationen av ett läkemedel eller läkemedelskomponent.">
					comment = <"Till exempel: \"tablett\", \"kapsel\", \"infusionsvätska\" eller \"inhalationspulver\". 
Kodning av formen med en terminologi är att föredra, där det är möjligt. Läkemedelskataloger kan skilja mellan administrerbar form 'lösning för injektion' och produktform 'pulver för injektionsvätska, lösning'. Den dokumenterade formen beror på det exakta sammanhanget för användning. Administrerbar form kommer sannolikt att användas i de flesta fall.">
				>
				["at0080"] = <
					text = <"Terapeutisk">
					description = <"Beståndsdel som ensam eller i kombination med en eller flera andra ingredienser anses uppfylla läkemedlets avsedda aktivitet.">
				>
				["at0083"] = <
					text = <"Adjuvant">
					description = <"Beståndsdel vars primära funktion är att modifiera aktiviteten hos en aktiv beståndsdel. En adjuvant beståndsdel kan i sig eller inte vara terapeutiskt aktiv.">
				>
				["at0084"] = <
					text = <"Hjälpämne">
					description = <"Beståndsdel som är trögt i förhållande till läkemedlets avsedda aktivitet.">
				>
				["at0115"] = <
					text = <"Styrka (koncentration)">
					description = <"Styrkan hos läkemedlet eller läkemedelskomponenten, som koncentration.">
					comment = <"*This element is used for liquid or semisolid medications, or medications intended to be diluted in a liquid before administration. For example: '10 mg/ml', '20 mg/g', '5 %', '10,000 SQ-U/ml'. If the 'Strength (presentation)' cluster is used, this element becomes redundant. (en)">
				>
				["at0127"] = <
					text = <"Roll">
					description = <"Läkemedlets eller läkemedelskomponentens roll i en blandning.">
				>
				["at0132"] = <
					text = <"Namn">
					description = <"Namnet på läkemedlet eller läkemedelskomponenten.">
					comment = <"Till exempel: 'Zinacef 750 mg pulver' eller 'cefuroxim'. Detta dataelement bör om möjligt kodas, med exempelvis RxNorm, DM + D, Australian Medicines Terminology eller FEST. Användningen av detta dataelement kommer att variera beroende på användningssammanhang. Detta dataelement kan utelämnas om läkemedlets namn registreras i föräldrarnas INSTRUKTION eller ÅTGÄRD, och denna arketyp endast används för att registrera att formen måste vara eller var \"flytande\".">
				>
				["at0133"] = <
					text = <"Beskrivning">
					description = <"Utförlig beskrivning av läkemedlet eller läkemedelskomponenten där det inte är möjligt att beskriva detta fullständigt med hjälp av de strukturerade dataelementen.">
				>
				["at0138"] = <
					text = <"Beståndsdelar">
					description = <"Detaljer om en ingrediens eller produkt som används för att göra en blandad förpackning, beredning eller infusion.">
					comment = <"Denna öppning är avsedd att användas för att lägga till detaljer om beståndsdelar i läkemedlet eller läkemedelskomponenten, med hjälp av nästlade instanser av denna arketyp. Detta krävs normalt inte annat än när en blandning beskrivs">
				>
				["at0139"] = <
					text = <"Mängd">
					description = <"*The amount of medication or medication component. (en)">
					comment = <"*For example: '1 ml', '1.5 mg', '1000 ml'.  (en)">
				>
				["at0141"] = <
					text = <"Strukturerade detaljer">
					description = <"Ytterligare information om läkemedlet eller läkemedelskomponenten.">
					comment = <"Till exempel: detaljerad information om läkemedelsklass eller avsedda administreringsvägar, eller ytterligare hållbarhetsinformation.
">
				>
				["at0142"] = <
					text = <"Kategori">
					description = <"Kategori av läkemedels- eller läkemedelskomponenten, med avseende på tillverkning eller beredning, och antalet ingredienser.">
					comment = <"Till exempel: 'Paracetamol/codeine' är en produkt med flera ingredienser, medan 'Morfin 60 mg + Haloperidol 2 mg + Midazolam 5 mg' är en ad-hoc-blandning vars sammansättning är fullständigt specificerad i beställningen.">
				>
				["at0143"] = <
					text = <"Ad-hoc blandning">
					description = <"Läkemedels- eller läkemedelskomponenten består av en blandning av ingredienser som anges i beställningen. Dessa bereds vanligtvis av apotek eller avdelningspersonal för att passa enskilda patienter">
				>
				["at0144"] = <
					text = <"Produkt med flera ingredienser">
					description = <"Läkemedels- eller läkemedelskomponenten består av ett antal aktiva ingredienser som i förväg kombineras till en enda form såsom en tablett eller pulver av tillverkaren, till exempel Paracetamol / kodein.">
				>
				["at0145"] = <
					text = <"En-ingrediens produkt">
					description = <"Läkemedlet eller läkemedelskomponenten är en tillverkad produkt som innehåller en enda aktiv ingrediens.">
				>
				["at0146"] = <
					text = <"Ingrediens">
					description = <"Läkemedlet eller läkemedelskomponenten är en enskild ingrediens i läkemedlet. Denna term används när arketypen är kapslad i en förälder-instans av sig själv för att beskriva de enskilda ingredienserna i ett läkemedel.">
				>
				["at0148"] = <
					text = <"Alternativ mängd">
					description = <"*An equivalent representation of the amount of the medication or medication component. (en)">
					comment = <"*For example: for a medication with a strength of '5 mg/ml' and where the Amount is '1 ml', and the value recorded in this data element would be '5 mg'. (en)">
				>
				["at0150"] = <
					text = <"Batch ID">
					description = <"Identifieraren som tillverkaren tilldelade batchen med, under produktionen.">
				>
				["at0151"] = <
					text = <"Tillverkare">
					description = <"Tillverkaren av läkemedlet eller läkemedelskomponenten.">
					comment = <"Till exempel: 'Abbott'.">
				>
				["at0152"] = <
					text = <"Styrka">
					description = <"Styrkan hos läkemedlet eller läkemedelskomponenten, uttryckt som ett förhållande.">
					comment = <"*In some cases, as for liquid or semisolid medications, the denominator of the strength ratio is a physical quantity, for example 2 mg/5 ml. In some of these cases the denominator also reflects the actual volume of the component: 5 ml in the previous example. In this case the 'Strength (concentration)' would be 0.4 mg/ml. In other cases, where the strength involves a denominator which is not a physical quantity, for example 4 mg/tablet, the denominator is expressed as a unitary value '1' with a unit of '1', and 'tablet' is carried in the 'Unit of presentation' element. This arrangement was chosen to align with the approach adopted by the ISO IDMP standard for medication catalogues. If the 'Strength (concentration)' element is used, this cluster becomes redundant. (en)">
				>
				["at0153"] = <
					text = <"Styrka i täljare">
					description = <"*The numerator of the strength fraction. (en)">
					comment = <"*For example: For a presentation strength of '300 µg/0.3 ml', the strength numerator is '300 µg'. For a presentation strength of '100 mg/tablet', the strength numerator value is '100 mg'. (en)">
				>
				["at0157"] = <
					text = <"Styrka i nämnare">
					description = <"*The denominator of the strength fraction. (en)">
					comment = <"*For example: For a presentation strength of '300 µg/0.3 ml', the strength denominator value is '0.3 ml'. For a presentation strength of '100 mg/tablet', the strength denominator value is '1 tablet'. (en)">
				>
			>
		>
	>